TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis

Junqiang Li(Unimed Medical Institute), Haichuan Su(Tang Du Hospital), Jing Yang(Tongji University), Yongdong Guo(Air Force Medical University), Peixiang Ma(Shanghai Ninth People's Hospital), Jingjie Shi(Air Force Medical University), Yang Song(Iberoamerican Cochrane Centre), Lei Hua(Xuzhou Medical College), Shanshan Li(Unknown), Chao Zhang(National Clinical Research Center for Digestive Diseases), Hong Li(Nanchang University), Xiaonan Liu(Shanghai Jiao Tong University), Cheng Yang(University of California, Riverside), Dongxue Gan(Ministry of Education of the People's Republic of China), Ronglin Wang(Air Force Medical University), Liaoliao Zhu(Air Force Medical University)
Cellular & Molecular Biology Letters
March 8, 2022
10.1186/s11658-022-00321-z
Cited by 23

Related Papers

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
|Cell|2019|1.2k
Global Variation in the Effects of Ambient Temperature on Mortality
|Epidemiology|2014|618
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
|Cell Death and Disease|2016|574
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma
|Allergy|2020|406
miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
|Molecular Cancer Research|2011|361